Log in

NASDAQ:ALQAAlliqua Biomedical Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range N/A
50-Day Range
MA: $2.81
52-Week Range N/A
Volume371,516 shs
Average Volume114,400 shs
Market Capitalization$13.46 million
P/E RatioN/A
Dividend YieldN/A
Alliqua BioMedical, Inc. develops, manufactures, and markets high water content, electron beam cross-linked, and aqueous polymer hydrogels or gels used in wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It also provides contract manufacturing services to the OEM market. The company is headquartered in Langhorne, Pennsylvania.
Read More
Alliqua Biomedical logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.75 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:ALQA



Sales & Book Value

Annual Sales$2.22 million
Book Value$1.65 per share


Net Income$-8,420,000.00
Net Margins-230.50%


Market Cap$13.46 million
Next Earnings DateN/A
OptionableNot Optionable

Receive ALQA News and Ratings via Email

Sign-up to receive the latest news and ratings for ALQA and its competitors with MarketBeat's FREE daily newsletter.

Alliqua Biomedical (NASDAQ:ALQA) Frequently Asked Questions

How were Alliqua Biomedical's earnings last quarter?

Alliqua Biomedical Inc (NASDAQ:ALQA) posted its quarterly earnings data on Tuesday, August, 9th. The company reported $0.50 earnings per share for the quarter, beating the Zacks' consensus estimate of ($2.70) by $3.20. The business had revenue of $5.50 million for the quarter, compared to analysts' expectations of $5.38 million. Alliqua Biomedical had a negative net margin of 230.50% and a negative return on equity of 71.73%. View Alliqua Biomedical's earnings history.

When did Alliqua Biomedical's stock split? How did Alliqua Biomedical's stock split work?

Alliqua Biomedical's stock reverse split on the morning of Friday, October 6th 2017. The 1-10 reverse split was announced on Thursday, October 5th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 5th 2017. An investor that had 100 shares of Alliqua Biomedical stock prior to the reverse split would have 10 shares after the split.

Has Alliqua Biomedical been receiving favorable news coverage?

News articles about ALQA stock have been trending positive on Saturday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Alliqua Biomedical earned a media sentiment score of 2.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutAlliqua Biomedical.

Who are some of Alliqua Biomedical's key competitors?

What other stocks do shareholders of Alliqua Biomedical own?

Who are Alliqua Biomedical's key executives?

Alliqua Biomedical's management team includes the following people:
  • Mr. David Ian Johnson, Pres, CEO, Principal Financial Officer & Director (Age 61)
  • Dr. Phillip D. Forman M.D., DPM, Exec. VP of Clinical Affairs (Age 60)
  • Mr. Joseph M. Warusz, CFO, Treasurer & Sec. (Age 63)

What is Alliqua Biomedical's stock symbol?

Alliqua Biomedical trades on the NASDAQ under the ticker symbol "ALQA."

How big of a company is Alliqua Biomedical?

Alliqua Biomedical has a market capitalization of $0.00 and generates $2.22 million in revenue each year. Alliqua Biomedical employs 6 workers across the globe.

What is Alliqua Biomedical's official website?

The official website for Alliqua Biomedical is www.alliqua.com.

How can I contact Alliqua Biomedical?

Alliqua Biomedical's mailing address is 2150 CABOT BLVD WEST SUITE B, LANGHORNE PA, 19047. The company can be reached via phone at 215-702-8550 or via email at [email protected]

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.